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Abstract
Objectives: Only few studies on gingival lesions considered large enough populations and contemporary litera-
ture does not provide a valid report regarding the epidemiology of gingival lesions within the Italian population. 
The histopathological and clinical appearance of 538 gingival lesions from northern Italians are described and 
discussed here.
Study Design: The case records of patients referred for the diagnosis and management of gingival lesions, from 
October 1993 to October 2009, were reviewed. Data regarding the histological type of lesion were also obtained 
from the biopsy register for each case, and blindly re-examined.
Results: We reported a greater frequency of benign lesions (reactive and/or inflammatory) in non-plaque/non-
calculus induced gingival disorders. We confirmed an unambiguous prevalence of oral squamous cell carcinoma 
above all other malignant neoplasia, and a prevalence of neoplastic malignant lesions in the maxilla, with a slight 
increase in females and a drift of the incidence peak from the seventh to the eighth decade. There was a prevalence 
of precancerous gingival lesions in the maxilla, with a higher incidence in females and with a drift from the sixth 
to the seventh decade. We also reported a prevalence of oral lichen planus and lichenoid lesions as major manifes-
tations of desquamative gingivitis.
Conclusions: The high frequency of gingival involvement of such different diseases emphasizes the importance of 
histological characterization and differential diagnosis for periodontists, but more prospective studies are needed 
to better describe the true incidence of the non-plaque related gingival diseases.
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Introduction
The gingiva is commonly affected by non-neoplastic 
and neoplastic lesions, the latter usually being char-
acterized by a progressive growth that can be either 
benign or malignant. Non-neoplastic lesions are either 
inflammatory or represent a reaction to diverse types 
of irritative stimuli. Moreover, the great majority of 
localised overgrowths of the gingiva are considered to 
be reactive rather than neoplastic in nature (1-3). Desq-
uamative gingivitis manifests predominantly as painful 
erosions or ulceration of the attached and free gingiva. 
It is now known to represent a common manifestation 
in a number of disorders ranging from bullous diseases 
to adverse reactions to a variety of chemicals or aller-
gens (4). An accurate comparison and evaluation of the 
findings obtained by previous epidemiological studies 
is difficult because of the limited number of reported 
cases; this is the reason why estimating the prevalence 
of gingival lesions worldwide proves to be an arduous 
task. Up to this date, few studies on gingival lesions 
considered large enough populations and contempo-
rary literature does not provide a valid report regarding 
the epidemiology of gingival lesions within the Italian 
population. The aim of this study was that of analysing 
clinical and histological features of gingival lesions in 
a Northern Italian population and to compare obtained 
data with those previously collected. 
Material and Methods
The case records of all patients, who had been initially 
referred to the Oral Medicine Unit of the main hospital 
of the city of Turin, Italy, for the diagnosis and manage-
ment of gingival lesions, from October 1993 to October 
2009, were reviewed and relevant retrospective data 
selected and extracted.  Demographic information, age 
and gender, smoking, alcohol consumption, clinical as-
pect of the lesions, and sites of oral involvement were 
collected.  To complete the final list, the following in-
clusion criteria were adopted: 1) all age groups and both 
sexes; 2) reports with complete and satisfactory case 
histories; 3) tissue samples obtained exclusively from 
gingiva, edentulous fibromucosa or alveolar mucosa; 4) 
more than one sample for a given patient, as long as 
biopsied at different times. 
Data regarding the histological type of lesion were ob-
tained from the biopsy register for each case. Haematoxy-
lin and eosin sections of each specimen were evaluated by 
light microscopy and blindly re-examined by an expert 
oral pathologist. 
The diseases were then classified into 4 groups by an expert 
oral physician (M.C.): a] neoplastic lesions (both malignant 
and benign); b] non-neoplastic lesions; c] oral premalignant 
lesions; d] lesions caused by autoimmune diseases.
All analyses were performed using SPSS software 
(SPSS for windows, version 11, SPSS inc, Chicago, IL, 
USA). All different data collected from each patient 
were later analysed using descriptive statistics. Con-
tinuous variables are expressed as mean ± SD.
Results
The study group involved 448 non-related Caucasian pa-
tients (269 females and 179 males) and 1 Afro-Caribbean 
female (F : M = 1.5 : 1). The mean age at presentation was 
57.5 years for men (SD ± 13.6) and 54.1 years for women 
(SD ± 12.8). The total number of biopsied samples resulted 
to be 538 and records showed that 68 patients underwent 
biopsy more than once (Table 1).
a. Neoplastic lesions (Table 2).
Malignant neoplastic lesions accounted for almost 8% 
of all biopsied gingival lesions. Twenty-five out of 43 
malignant tumours were diagnosed as oral squamous 
cell carcinoma (60%) (Fig. 1), 8 resulted to be a verru-
cous carcinoma (19%), 4 were B cell non-Hodgkin lym-
phomas (Fig. 2, 3) ,2 were diagnosed as acute myeloid 
leukaemia, 2 as melanoma, 1 as chronic lymphocitic 
leukaemia and 1 resulted to be a metastasis of a primary 
intestinal adenocarcinoma. When considering sampling 
sites, the majority of surgical samples were obtained 
from the maxillary attached gingiva (n=17), followed 
by the mandibular alveolar mucosa (n=13), the maxil-
lary alveolar mucosa (n=7) and finally the mandibular 
attached gingiva (n=6). When considering the 25 cases 
of squamous cell carcinoma, the male to female ratio re-
sulted to be nearly 1:1, whereas in verrucous carcinoma it 
  m : f N° Mandible Maxilla 
Neoplastic lesions      
 Malignant 1 : 1.1 43 19 24 
 Benign 1 : 0.6 25 14 11 
Non-neoplastic lesions      
 Reactive  inflammatory 1 : 1.8 54 17 37 
 Others 1 : 0.7 204 84 120 
Premalignant lesions  1 : 0.5 74 29 45 
Autoimmune diseases  1 : 4.7 138 53 85 
Total  1 : 1.5 538 207 331 
 
Table 1. Frequency and site distribution of 538 gingival specimens.
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was equal to 1.7:1. Leukaemia, lymphoma and metastases 
were found in females only; on the other hand, melanomas 
were diagnosed exclusively in men. The highest number 
of malignant lesions was detected in patients aged 60 to 
69 whilst no manifestation of such lesions was found in 
patients under the age of 20.  Benign neoplastic lesions 
were classified as squamous papilloma (56%), hemangi-
oma (16%), lipoma (12%), schwannoma (8%), peripheral 
odontogenic fibroma (4%), odontoma (4%). The most com-
monly involved localisation resulted to be the maxillary 
attached gingiva, with a higher incidence in males and two 
incidence peaks (fifth and eight decade).  
b. Non-neoplastic lesions (Table 3).
Mainly localized reactive hyperplastic lesions belong to 
 type m : f N° Mandible Maxilla 
Neoplastic lesions      
   Benign°      
 OSP 1 : 0.5 14 7 7 
 HM 1 : 0.5 4 3 1 
 LIP 1 : 0 3 2 1 
 SC 1 : 0 2 1 1 
 POF 1 : 0 1 1 - 
 ODO 1 : 1 1 - 1 
Malignant*      
 SCC 1 : 0.9 25 12 13 
 VC 1 : 0.6 8 2 6 
 AML 0 : 1 2 - 2 
 CLL 0 : 1 1 1 - 
 NHL 0 : 1 4 1 3 
    MTS 0 : 1 1 1 - 
 OMM 1 : 0 2 - 2 
           Total  1 : 0.8 68 31 37 
 
Table 2. Frequency and site distribution of neoplastic gingival lesions.
° Benign lesions. OSP: oral squamous papilloma; HM: haemangioma; LIP: lipo-
ma; SC: schwannoma; POF: peripheral odontogenic fibroma; ODO: odontoma.
*Malignant lesions. SCC: squamous cell carcinoma; VC: verrucous carcinoma; 
AML: acute myeloid leukemia; CLL: chronic lymphocytic leukemia; NHL: 
non-hodgkin’s lymphoma; MTS: metastasis from intestine adenocarcinoma; 
OMM: oral malignant melanoma. 
Fig. 1. Clinical view of a squamous cell carcinoma on the right max-
illary premolar gingival area.
Fig. 2. Clinical view of an upper gingival case of B cell non-Hodgkin 
lymphomas.
Fig. 3. Clinical view of a diffuse gingival involvement in a patients 
with a diagnosis of plasma cell gingivitis.
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 type m : f N° Mandible Maxilla 
Non- neoplastic lesions      
               RHL°      
 �CE 1 : 2.2 14 7 7 
 PCE 1 : 2.7 12 3 9 
 FBE 1 : 1 11 2 9 
 FAE 1 : 3 8 3 5 
 PY� 1 : 5 7 2 5 
 �C� 1 : 0.5 6 3 3 
       Others*      
 HYP 1 : 0.8 79 29 50 
 KER 1 : 0.3 49 17 32 
 NSU 1 : 0.8 18 9 9 
 CN� 1 : 1.8 17 7 10 
    others 1 : 1.2 37 19 18 
             Total  1 : 0.9 258 101 157 
 
Table 3. Frequency and site distribution of non-neoplastic gingival lesions.
°Reactive hyperplastic lesions (RHL). �CE: giant cell epulis; PCE: plasmacellular epu-
lis; FBE: fibromatous epulis; FAE: fibroangiomatous epulis; PYG: pyogenic granuloma; 
�C�: peripheral giant cell granuloma.
*Non-differently classified lesions. HYP: hyperplasia; KER: keratosis; NSU: non-specif-
ic ulcer; CNG: chronic non-specific gingivitis.
this group. They were classified as follows: giant cell 
epulis (24%), plasmacellular epulis (20%), fibroma-
tous epulis (15%), fibroangioma epulis (15%), pyogenic 
granuloma (11%), peripheral giant cell granuloma (11%). 
The maxillary attached gingiva appeared to be the most 
commonly involved site and females represented the ma-
jority of patients, with an incidence peak in the fourth 
decade. Amongst the other encountered pathologies we 
diagnosed undifferentiated hyperplasia (38%), keratosis 
(23%), non-specific ulcer (9%), chronic non-specific gin-
givitis (9%), and a smaller number of periodontal cysts, 
amalgam tattoos, melanotic maculae, racial pigmenta-
tion, lentigo simplex, sarcoidosis and amyloidosis (all 
ranging between 3 and 1%). Such lesions were mostly 
seen in males with the exception of cysts and chronic 
gingivitis. They reached a peak of incidence around the 
seventh decade and involved males and females almost 
equally (47% and 53% respectively). 
c. Oral premalignant lesions
Premalignancies represented almost 14% of all lesions 
(74 overall). The following encountered lesions belong to 
this group: leukoplakia without dysplasia 86.4% (n=64), 
leukoplakia with mild dysplasia (n=7), leukoplakia with 
moderate dysplasia (n=2), and erythroplakia with severe 
dysplasia (n=2). The elective localisation of such lesions 
appeared to be the attached gingiva of the maxilla (51.3%). 
The majority of subjects to undergo a biopsy and to obtain 
the subsequent diagnosis of precancerous lesion were fe-
males (67.8%). When considering age distribution, prema-
lignant lesions showed an incidence peak around the sev-
enth decade, even though these lesions can be detected at 
any age. Conversely, dysplasia reached an incidence peak 
around the eight decade. 
d. Autoimmune diseases (Table 4).
Oral lichen planus showed to be the most frequent pathol-
 type m : f N° Mandible Maxilla 
Autoimmune diseases°      
 OLP 1 : 4 53 20 33 
 OLL 1 : 8.3 38 18 20 
 MMP 1 : 3.7 24  5 19 
 PV 1 : 5.5 13  5  8 
 DIgA 1 : 1  2  1 1 
 �VHD 1 : 0  3  2  1 
 PC� 1 : 1  5  2  3 
Total  1 : 4.7 138 53 85 
 
Table 4. Frequency and site distribution of autoimmune gingival diseases.
° OLP: oral lichen planus; OLL: oral lichenoid lesion; MMP: mucous membrane pemphi-
goid; PV: pemphigus vulgaris; DIgA: linear IgA dermatosis; �VHD: graft versus host 
disease; PCC: plasma cell gingivitis (Fig. 3).
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ogy, representing 38.4% of all disimmune diagnoses, fol-
lowed by oral lichenoid lesions (27.5%), mucous membrane 
pemphigoid (17.4%) and pemphigus vulgaris (9.4%). The 
attached gingiva was the most commonly involved tissues 
(64%); an exception to this was represented by pemphi-
goid, as the majority of tissue samples were taken from 
the maxillary alveolar mucosa. Females were the most 
represented group (81.1%) and the incidence resulted to be 
higher in the sixth decade. 
Discussion
To the best of our knowledge, this study represents the 
first report on the frequency and distribution of biopsied 
gingival lesions within the Northern Italian population. 
The clinical and histological features of patients in our 
survey share many similarities with those reported pre-
viously in other countries, but we also reported some 
essential differences.
The majority of samples (37.2%) led to the diagnosis 
of non-neoplastic lesions (inflammatory reactive lesions 
and other non-definable nor specific lesions). Within 
this group, gingival hyperplasia resulted to be the most 
common histopathological manifestation. Such results 
agree with those previously reported in the literature 
(5-9). Although the total number of those gingival le-
sions was higher in females, non-neoplastic lesions were 
equally distributed among males and females, with an 
insignificant prevalence in the former group. Moreover, 
our results have pointed out an incidence peak, con-
cerning all non-neoplastic lesions, in patients aged 60 
to 69. In contrast with this, two analogous studies had 
previously highlighted how the majority of biopsies had 
been carried out in patients aged 30-39 (8), and 20-29 
(5). The difference between these results and ours is 
probably bound to the different criteria adopted to clas-
sify lesions. The present study does, in fact, subdivide 
non-neoplastic lesions into reactive hyperplastic and 
non-definable/specific lesions, whereas other authors 
merge all non-neoplastic benign lesions into one group. 
Interestingly enough, when considering our results con-
cerning reactive inflammatory lesions alone, we have 
noticed an incidence peak between 30 and 39 years of 
age, thus consistently in agreement with the previously 
mentioned studies.
Malignant neoplastic lesions represented 8% of all di-
agnosed gingival lesions. Such a finding is different 
from the incidence reported in the literature, ranging 
from 1 to 3.5% (5, 8-19). Amongst these, Layfield and 
co-workers in particular carried out more than 30.000 
gingival biopsies over a period of 24 years and reported 
an incidence of malignant lesions equal to 1.4% (8). 
Such a noteworthy difference certainly underlines how 
all those authors tend to include periodontal disorders 
into the considered gingival lesions, thus occupying the 
majority of the sample. When considering the distribu-
tion of disorders within the malignant neoplasia group, 
we found squamous cell carcinoma to prevail on all the 
others, similarly to previous findings (6,8, 12-19). Data 
analysis revealed that the second most common diagno-
sis of malignancy resulted to be that of verrucous carci-
noma with an incidence of 19% out of all malignant neo-
plasias, according to our previous published data (20,21). 
Although the literature generally describes the attached 
gingiva and the alveolar mucosa in the mandible as being 
the preferential location of malignant neoplasia, and the 
mandible for all different types of oral tumour (12,13), 
the data collected in the present study actually highlight-
ed the prevalence of such type of malignant lesions in the 
attached gingiva and alveolar mucosa of the maxilla. The 
analysis of our archives did, in fact, reveal 26 biopsies in 
the maxilla and 17 in the mandible that finally led to such 
diagnosis. The latter would appear to be the most original 
and significant result of our work, and it certainly is in 
contrast with previously published studies, even though 
we cannot supply any clear nor univocal interpretation 
about it. Oral melanoma has previously been reported 
with a frequency varying from 0.2 to 8% (22) but more 
recent data are missing; within the population considered 
by this study, its frequency was equal to 5%. Oral malig-
nant melanomas mostly occur in the palate and gingiva, 
with the maxillary arch affected in most of the cases, 
and our results confirmed this. When considering data 
regarding the distribution of malignancies according to 
age and gender, our results do reflect those reported in the 
literature. All, in fact, agree on emphasizing a slight and 
progressive increase of malignancies in females over the 
last decade (12,18). Such an event is probably owed to the 
fact that they are now more exposed to risk factors than 
they were in the past. In addition to this, the incidence 
peak has moved from the seventh to the eight decade of 
human life as our race is surviving for longer (18).
In our report, precancerous lesions represented almost 
14% of all biopsies; 14.8% of these were diagnosed as 
epithelial dysplasia of different degrees and such a re-
sult is in agreement with Layfield and coworkers (8). 
Previous studies described the prevalence of leukopla-
kia without dysplasia to range between 18 and 38% (23-
26), whilst the present study has detected a prevalence 
of gingival leukoplakia of 86.4% within the considered 
population. Such a result is justified by a complete lack 
in the literature of an analysis on leukoplakias localized 
solely on the gingiva. In fact, all the above-mentioned 
studies took care of evaluating the distribution of leu-
koplakia within the whole of the oral cavity. In this 
case gingival and alveolar mucosa occupied the third 
and fourth place respectively, following floor of the oral 
cavity, tongue and vestibular mucosa. These studies do, 
however, describe a slight prevalence in the mandible 
and this is once again in contrast with our results.
The existing classification system for periodontal dis-
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eases includes, among non plaque–induced gingival 
disorders, ‘‘gingival manifestations of systemic condi-
tions’’. Several mucocutaneous disorders (e.g., oral li-
chen planus, mucous membrane pemphigoid, pemphi-
gus vulgaris, erythema multiforme, lupus erythemato-
sus and others) are listed in this subgroup together with 
allergic reactions (27). Besides their heterogeneous na-
ture, all of these diseases share two common character-
istics: an immunomediated pathogenesis and a similar 
clinical appearance with erythematous lesions, blisters, 
erosions, and ulcers, mainly located on the attached 
gingiva and palatal mucosa.  Those clinical features are 
described as “desquamative gingivitis” (D�), one of the 
most important manifestations of disimmune diseases. 
The attached gingiva and the alveolar mucosa are pref-
erential sites for biopsy in all D�s. Clinical features of 
desquamative gingivitis in relation to the most common 
disimmune disorders have been highlighted by two 
studies in particular (28). These have shown that the 
most frequently associated disease is pemphigoid, fol-
lowed by oral lichen planus and by pemphigus vulgaris. 
Within the population included in the present study, 
desquamative gingivitis was most frequently associated 
with oral lichen planus and lichenoid lesions, followed 
by mucous membrane pemphigoid and pemphigus vul-
garis. The elevated number of cases presented by our 
study makes such a result original. We have observed 
a prevalence of disimmune disorders in females and 
an incidence peak in the age range 60-69. Whilst the 
former result is in agreement with the literature (29), the 
latter is in contrast with the study conducted by Lozada 
and co-workers (30), who reported a higher frequency 
in females aged 50-59. None of the previously published 
researches clearly described the localisation and distri-
bution of gingival manifestations of disimmune disor-
ders. The present study does, instead, underline a neat 
prevalence on the attached gingiva and alveolar mucosa 
of the maxilla. Such a result could be bound to a tech-
nical choice carried out by the operator: it is possibly 
easier and simpler to carry out a maxillary rather than 
a mandibular biopsy of the soft tissues (the majority of 
such disorders has, in fact, multiple localisations). 
In conclusion, our results confirm a greater frequency of 
benign lesions in non-plaque/non-calculus induced gin-
gival disorders. We confirmed an unambiguous preva-
lence of oral squamous cell carcinoma above all other 
malignant neoplasia, and, for the first time ever, an ab-
solute prevalence of neoplastic malign gingival lesions 
in the maxilla. We do confirm the slight increase of inci-
dence of oral malignancies in females and a drift of the 
incidence peak from the seventh to the eighth decade. 
This research is the first to highlight a prevalence of pre-
cancerous gingival lesions in the maxilla, which takes 
place with a higher incidence in females and with a drift 
from the sixth to the seventh decade. Finally, this study 
is original and unique in showing a prevalence of oral 
lichen planus and lichenoid lesions as major manifesta-
tions of desquamative gingivitis in a cohort of patients 
from the same clinic. The high frequency of gingival 
involvement of such different diseases emphasizes the 
importance of histological characterization and differ-
ential diagnosis for periodontists, but more prospective 
studies are needed to better describe the real incidence 
of non-plaque related gingival diseases.
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